Search - tctmd.com

Displaying 101 - 120 of 121

Sort: Relevancy | Date

News Daily News

Paclitaxel DCBs Now Implicated in Death, Amputation in Below-the-Knee CLI

L.A. McKeown

January 15, 2020

News Daily News

NOBLE at 5 Years: New Data Favor CABG for Left Main Disease

Todd Neale

December 23, 2019

TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X

Michael O'Riordan

November 22, 2019

News Conference News VIVA 2019

Nearly 1 Year Later, Endovascular Community Continues to Struggle With Paclitaxel

L.A. McKeown

November 08, 2019

News Opinion Conversations in Cardiology

Conversations in Cardiology: Should Interventional Cardiologists Get Paid for Being On Call?

November 08, 2019

News Daily News

German Analysis Supports Long-term Safety of Paclitaxel-Based Therapies

L.A. McKeown

October 09, 2019

News Daily News TCT 2019

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

L.A. McKeown

October 02, 2019

News Conference News TCT 2019

‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures

L.A. McKeown

September 28, 2019

News Conference News TCT 2019

Robotics and Augmented Reality Show Promise for Improving Access to Care, Reducing Patient Anxiety

L.A. McKeown

September 25, 2019

News Daily News

Radial PCI Up, but Vascular Complication Rates Haven’t Budged

Yael L. Maxwell

August 29, 2019

News Daily News

Normal ECG? Artificial Intelligence Disagrees, Spots Signs of A-fib

Marcus A. Banks

August 02, 2019

News Conference News ESC Heart Failure 2019

Early Peek Hints at Safety and Utility of V-LAP Sensor for Monitoring Left Atrial Pressure

Shelley Wood

May 29, 2019

News Daily News

Patients Retain Little From Cath Lab Informed-Consent Conversations

Michael O'Riordan

April 26, 2019

Time and Money: PCI Public Reporting Requirements Takes Their Toll

News Conference News ACC 2019

Time and Money: PCI Public Reporting Requirements Take Their Toll

Michael O'Riordan

March 26, 2019

News Conference News CRT 2019

Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy

L.A. McKeown

March 06, 2019

News Daily News

No Excess Mortality Risk With Paclitaxel Stents in PAD, Second Medicare Analysis Finds

L.A. McKeown

March 01, 2019

News Daily News

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

L.A. McKeown

February 13, 2019

News Daily News

Cancer Patients Should Not Be Automatically Ruled Out for TAVR: Analysis

L.A. McKeown

January 10, 2019

News Daily News

Tailoring Antiplatelet Therapy to Bleeding Risk Post-PCI Improves Outcomes and Cuts Costs, Model Suggests

L.A. McKeown

January 08, 2019

News Daily News

Hospitals With Higher SAVR Mortality Likely to Have Higher TAVR Mortality, Too

L.A. McKeown

December 12, 2018

Advertisement

Paclitaxel DCBs Now Implicated in Death, Amputation in Below-the-Knee CLI

NOBLE at 5 Years: New Data Favor CABG for Left Main Disease

TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X

Nearly 1 Year Later, Endovascular Community Continues to Struggle With Paclitaxel

Conversations in Cardiology: Should Interventional Cardiologists Get Paid for Being On Call?

German Analysis Supports Long-term Safety of Paclitaxel-Based Therapies

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures

Robotics and Augmented Reality Show Promise for Improving Access to Care, Reducing Patient Anxiety

Radial PCI Up, but Vascular Complication Rates Haven’t Budged

Normal ECG? Artificial Intelligence Disagrees, Spots Signs of A-fib

Early Peek Hints at Safety and Utility of V-LAP Sensor for Monitoring Left Atrial Pressure

Patients Retain Little From Cath Lab Informed-Consent Conversations

Time and Money: PCI Public Reporting Requirements Take Their Toll

Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy

No Excess Mortality Risk With Paclitaxel Stents in PAD, Second Medicare Analysis Finds

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

Cancer Patients Should Not Be Automatically Ruled Out for TAVR: Analysis

Tailoring Antiplatelet Therapy to Bleeding Risk Post-PCI Improves Outcomes and Cuts Costs, Model Suggests

Hospitals With Higher SAVR Mortality Likely to Have Higher TAVR Mortality, Too

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content